Document is current
Any future updates will be listed below
-
Authors
Pensier, Joris
Touaibia, Maha
Meerun, Mohamad Azhar
Hefteh, Philippe
Bloncourt, Nicolas
Vonarb, Aurélie
Prades, Albert
al Taweel, Bader
Debourdeau, Antoine
Monino, Laurent
Chanques, Gérald
Molinari, Nicolas
de Jong, Audrey
Guiu, Boris
Jaber, Samir
- License Information
-
More Information
Article History
Received: 15 December 2025
Accepted: 6 January 2026
First Online: 16 January 2026
Declarations
:
: We obtained approval from the Montpellier University Hospital ethics committee for the Forever project on May 29, 2019 (Comité Local d’Ethique Recherche, agreement number: 2019_IRB-MTP_05-25). The requirement for informed consent was waived, and the opportunity to opt out of the study was provided. The study has been performed in accordance with the Helsinki declaration of 1975.
: Pr. Jaber reports receiving consulting fees from Drager, Duomed, Medtronic, Baxter, Fresenius-Xenios, Mindray, and Fisher & Paykel. Dr. De Jong reports receiving consulting fees from Medtronic, Dräger, Viatris and Fisher & Paykel. Pr Guiu reports receiving consulting fees from Canon Medical System, Roche, Guerbet, Terumo, Boston Scientific, Astra Zeneca, and research grants from Roche, Boston Scientific, Guerbet. Dr Monino reports receiving consulting fees from Taewoong Medical, Fujifilm, Braun Medical, Prion Medical, and speaker’s fees from Olympus Belgium and Olympus Europe. The others authors report no competing interests.
